David H Canaday
Overview
Explore the profile of David H Canaday including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
2406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oyebanji O, Yin A, Sundheimer N, Ragavapuram V, Shea P, Cao Y, et al.
Aging Clin Exp Res
. 2025 Mar;
37(1):73.
PMID: 40055264
Background: Data suggest that antibody responses following COVID-19 vaccines are a correlate of protection. Some studies, including the clinical trials of COVID-19 mRNA vaccines, did not stratify and evaluate whether...
2.
McConeghy K, Davidson H, Canaday D, Han L, Hayes K, Baier R, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2452677.
PMID: 39745702
Importance: Influenza vaccination remains the most important intervention to prevent influenza morbidity and mortality among nursing home residents. The additional effectiveness of recombinant influenza vaccine vs standard dose vaccines was...
3.
Roederer A, Cao Y, St Denis K, Sheehan M, Li C, Lam E, et al.
Cell Rep Med
. 2024 Dec;
5(12):101850.
PMID: 39657661
With the onset of the COVID-19 pandemic 4 years ago, viral sequencing continues to document numerous individual mutations in the viral spike protein across many variants. To determine the ability...
4.
Didion E, Kass J, Wilk D, Buss E, Frischmann S, Rubeck S, et al.
medRxiv
. 2024 Nov;
PMID: 39484240
Background: The CDC recommends the more immunogenic adjuvanted and high-dose flu vaccines over standard-dose, non-adjuvanted vaccines for individuals above 65 years old. The current study compares adjuvanted trivalent inactivated flu...
5.
Abul Y, Nugent C, Vishnepolskiy I, Wallace T, Dickerson E, Holland L, et al.
Geroscience
. 2024 Oct;
PMID: 39395130
SARS-CoV-2 vaccination has reduced hospitalization and mortality for nursing home residents (NHRs) but emerging variants and waning immunity challenge vaccine effectiveness. This study assesses the immunogenicity of the most recent...
6.
Gravenstein S, DeVone F, Oyebanji O, Abul Y, Cao Y, Chan P, et al.
EBioMedicine
. 2024 Jun;
105:105180.
PMID: 38861869
Background: Bivalent SARS-CoV-2 vaccines were developed to counter increasing susceptibility to emerging SARS-CoV-2 variants. We evaluated the durability of immunity and protection following first bivalent vaccination among nursing home residents....
7.
Oyebanji O, Sundheimer N, Ragavapuram V, Wilson B, Abul Y, Gravenstein S, et al.
Geroscience
. 2024 May;
46(6):6183-6194.
PMID: 38789833
Infections, despite vaccination, can be clinically consequential for frail nursing home residents (NHR). Poor vaccine-induced antibody quality may add risk for such subsequent infections and more severe disease. We assessed...
8.
Smith C, Didion E, Aung H, Tamilselvan B, Bej T, Oyebanji O, et al.
J Infect Dis
. 2024 May;
230(3):635-644.
PMID: 38743816
Background: Vaccines and vaccine boosting have blunted excess morbidity and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in older nursing home residents (NHR). However, the impact of...
9.
Abul Y, Nugent C, Vishnepolskiy I, Wallace T, Dickerson E, Holland L, et al.
medRxiv
. 2024 Apr;
PMID: 38585784
Background: SARS-CoV-2 vaccination has reduced hospitalization and mortality for nursing home residents (NHRs). However, emerging variants coupled with waning immunity, immunosenescence, and variability of vaccine efficacy undermine vaccine effectiveness. We...
10.
Roederer A, Cao Y, St Denis K, Sheehan M, Li C, Lam E, et al.
medRxiv
. 2024 Mar;
PMID: 38496628
Since the COVID-19 pandemic began in 2020, viral sequencing has documented 131 individual mutations in the viral spike protein across 48 named variants. To determine the ability of vaccine-mediated humoral...